CL
JAZZ icon

CSS LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

CSS LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7M Buy
+29,041
New +$6.36M 0.27% 66
2022
Q3 		– Sell
-1,600
Closed -$243K – 1111
2022
Q2 		$250K Sell
1,600
-5,491
-77% -$845K 0.01% 762
2022
Q1 		$1.1M Buy
7,091
+1,013
+17% +$147K 0.04% 406
2021
Q4 		$774K Buy
6,078
+2,700
+80% +$355K 0.03% 512
2021
Q3 		$440K Hold
3,378
– – 0.02% 672
2021
Q2 		$600K Buy
+3,378
New +$585K 0.02% 576

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CSS LLC's JAZZ Position: Q2 2026 in Review

CSS LLC opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 29,041 shares worth $7M. The stake represents 0.27% of the portfolio and ranks #66 among its holdings. This is a return to the name: CSS LLC previously reported a position in JAZZ as recently as Q2 2022.

CSS LLC first reported a position in JAZZ in Q2 2021 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • CSS LLC held 29,041 shares of Jazz Pharmaceuticals worth $7M as of Q2 2026.
  • Jazz Pharmaceuticals was a new CSS LLC position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.27% of CSS LLC's portfolio in Q2 2026, its #66 holding.
  • CSS LLC first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.